Summary
This prediction ended on 16.02.16 with a price of €3.04. The prediction for Evotec SE disappointed with a performance of -19.30%. Traumtanz has a follow-up prediction for Evotec SE where he still thinks Evotec SE is a Buy. Traumtanz has 50% into this predictionEvotec is a German-based biotech company that provides drug discovery and development solutions to pharmaceutical and biotechnology companies. The company operates in the fields of neuroscience, immunology, oncology, and infectious diseases, and its services include hit identification, target validation, and preclinical and clinical development. Evotec has partnerships with major pharmaceutical companies and has developed its own pipeline of drugs, with a focus on developing treatments for conditions such as Alzheimer's disease and diabetes. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of approximately €5.5 billion.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Evotec SE | 4.652% | 4.652% | -42.066% | -71.522% |
iShares Core DAX® | -0.922% | -1.078% | 12.165% | 16.796% |
iShares Nasdaq 100 | 0.371% | -0.556% | 38.622% | 49.370% |
iShares Nikkei 225® | 2.224% | -2.825% | 19.015% | 4.643% |
iShares S&P 500 | -0.026% | -0.788% | 28.485% | 42.479% |
According to Traumtanz what are the pros and cons of Evotec SE for the foreseeable future?
Pros
Cons
Comments by Traumtanz for this prediction
In the thread Evotec AG diskutieren
Traumtanz stimmt der Buy-Einschätzung von HuberSascha zu
Traumtanz stimmt am 11.08.2015 der Buy-Einschätzung von HuberSascha mit dem Kursziel 5.0€ zu.
Es tut sich einiges....die Pille gegen den Krebs zusammen mit Apeiron und Sanofi!